An Open Label Pilot Study Evaluating Safety and Efficacy of Divalproex Sodium (Depakote ER) in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 22 May 2015
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 13 Apr 2011 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 26 Nov 2005 New trial record.